Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.8 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |